By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: CEA Industries Files Complaint Against 10X Capital
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Technology > CEA Industries Files Complaint Against 10X Capital
CEA Industries Files Complaint Against 10X Capital
Technology

CEA Industries Files Complaint Against 10X Capital

GlobeNews Wire
Last updated: 23/05/2026 2:38 PM
GlobeNews Wire
Published: 23/05/2026
Share
SHARE

Louisville, CO, May 22, 2026 (GLOBE NEWSWIRE) — CEA Industries Inc. (Nasdaq: BNC) (“BNC” or the “Company”), today announced that it has filed a complaint against 10X Capital LLC (“10X”), the Company’s Asset Manager.

The complaint, filed in United States District Court for the District of Delaware, seeks a declaration that an oppressively one-sided Asset Management Agreement (“AMA”) is void from inception as unconscionable and ordering all fees paid by the Company to 10X under the AMA be returned to the Company.

About CEA Industries Inc.

CEA Industries Inc. (Nasdaq: BNC) is a growth-oriented company that has focused on building category-leading businesses in consumer markets, including building and managing the world’s largest corporate treasury of BNB.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements.” The statements in this press release that are not purely historical are forward-looking statements which involve risks and uncertainties. BNC wishes to caution readers that these forward-looking statements may be affected by the risks and uncertainties in BNC’s business as well as other important factors that may have affected and could in the future affect BNC’s actual results and could cause BNC’s actual results for subsequent periods to differ materially from those expressed in any forward-looking statement made by or on behalf of BNC. In evaluating these forward-looking statements, readers should consider various risk factors, including BNC’s ability to keep pace with new technology and changing market needs; BNC’s ability to finance its current business and proposed future business, including the ability to finance the continued acquisition of BNB; the competitive environment of BNC’s business; and the future value and adoption of BNB. Forward-looking statements are subject to numerous conditions and risks, many of which are beyond BNC’s control. In addition, these forward-looking statements and the information in this press release are qualified in their entirety by cautionary statements and risk factor disclosures contained in BNC’s filings with the SEC. Copies of BNC’s filings with the SEC are available on the SEC’s website at www.sec.gov. BNC undertakes no obligation to update these statements for revisions or changes after the date of this press release, except as required by law.

CEA Industries Media Inquiries:
Edelman Smithfield
CEA@edelmansmithfield.com

CEA Industries Investor Relations:
james@haydenir.com

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
The Lamborghini Temerario GT3 Born and bred in SantAgata Bolognese
Avicanna Announces Change in CFO
Equiti Group strengthens multi-asset offerings with TraderEvolution partnership
IMG Announces Ninth Annual ‘Leave Your Mark’ Grant Opportunity
TAGGED:10xagainstcapitalceacomplaintfilesindustriesNasdaq:BNCNasdaq:BNCWWNasdaq:BNCWZnewsUS86887P1012
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY (Paltusotine) in Acromegaly at ENDO 2025
Health

Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY (Paltusotine) in Acromegaly at ENDO 2025

GlobeNews Wire
GlobeNews Wire
14/07/2025
GTPL Hathway Ltd : Profit Before Tax (PBT) increases by 14% Y-o-Y in Q3 FY26
LYKSTAGE Launches Patented Video Platform That Pays Creators and Viewers — Now Live Across Five Countries
Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative personalized off-the-shelf immunotherapy toward clinical development
Criminal IP Reveals Global React2Shell RCE Exposure Across React Server Components
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?